Skip to main content
. 2017 Jun 19;14(2):2393–2398. doi: 10.3892/ol.2017.6410

Table I.

Association between tumor necrosis factor receptor 2 and clinical parameters of patients with breast cancer.

TNFR2 expression, n

Clinical parameters Cases, n Low High P-value
Total 125 71 54
Age 0.788
  <35 years   40 22 18
  ≥35 years   85 49 36
Menopausal status 0.156
  No   49 24 25
  Yes   76 47 29
Family history 0.245
  No 105 62 43
  Yes   20   9 11
Tumor size 0.006a
  <5 cm 109 67 42
  ≥5 cm   16   4 12
Lymph node involvement 0.188
  No   61 31 30
  Yes   64 40 24
Clinical stage 0.011a
  I/II   93 59 34
  III   32 12 20
Pathological grade 0.004a
  G1/G2 106 66 40
  G3   19   5 14
Pathological type 0.379
  Ductal invasive   84 50 34
  Others   41 21 20
ER, PR and HER2 status 0.607
  Triple-negative   33 20 13
  Non-triple-negative   92 51 41
a

P<0.05. TNFR2, tumor necrosis factor receptor 2; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2.